CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Motility modulation beyond MCP and domperidon: Mechanisms of action of a clinically proven medicine, STW 5, in functional GI diseases
DOI 10.1055/s-0035-1559275
Bibliografische Angaben
Nachweis in CareLit
Autor:innenO Kelber, S Hoser, H Abdel-Aziz, S Okpanyi, K Nieber
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Motility-modulating drugs have been an important therapeutic approach in functional GI diseases. This approach has been questioned by the withdrawal of the prokinetic drug cisapride from the market and now again by the referrals for metoclopramide (MCP) and domperidon leading to the omission of functional dyspepsia and gastrooesophageal reflux disease from its therapeutic indications. As has been recen…
Zitieren
Zitierempfehlung
O Kelber, S Hoser, H Abdel-Aziz, S Okpanyi, K Nieber (2015) Motility modulation beyond MCP and domperidon: Mechanisms of action of a clinically proven medicine, STW 5, in functional GI diseases. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0035-1559275
Mit CareLit weiterarbeiten